Encompass Health Reports Strong Q1 Earnings with Revenue Growth and Guidance Raise
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 02 2026
0mins
Should l Buy EHC?
Source: Yahoo Finance
- Significant Revenue Growth: Encompass Health reported a 9% increase in Q1 revenue to $1.59 billion, with adjusted EBITDA rising 11.2% to $348.8 million, reflecting strong market performance and prompting an upward revision of 2026 guidance.
- Improved Patient Outcomes: The discharge community rate improved by 50 basis points to 84.5%, exceeding industry averages, indicating significant progress in enhancing patient outcomes and strengthening the company's competitive position.
- Optimized Human Resource Management: RN turnover decreased to 17.8%, the lowest since 2012, contributing to a 9.4% decline in premium labor spend, showcasing the company's successful strategies in employee retention and development.
- Expansion Plans Implementation: The company plans to open 7 new hospitals and add 100 to 150 beds to existing facilities to meet strong demand for inpatient rehabilitation services, further solidifying its market position and enhancing service capacity.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy EHC?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on EHC
Wall Street analysts forecast EHC stock price to rise
5 Analyst Rating
5 Buy
0 Hold
0 Sell
Strong Buy
Current: 107.150
Low
134.00
Averages
146.75
High
160.00
Current: 107.150
Low
134.00
Averages
146.75
High
160.00
About EHC
Encompass Health Corporation is an owner and operator of inpatient rehabilitation hospitals in the United States. The Company provides compassionate rehabilitative care for patients recovering from a major injury or illness, using advanced technology and treatments to maximize recovery. It operates hospitals in 38 states and Puerto Rico, with concentrations in Florida and Texas. It operates approximately 166 inpatient rehabilitation hospitals. Its inpatient rehabilitation hospitals offer specialized rehabilitative care across an array of diagnoses and deliver comprehensive patient care services. It provides care to patients who suffer from cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures and a variety of debilitating neurological conditions. Its hospitals have settings for treating the debilitating effects of the COVID-19 virus, such as significant muscle weakness, cognitive impairments, shortness of breath with activity and malnutrition.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Encompass Health Acquires Land for New Rehabilitation Hospital in Texas
- Successful Land Transaction: Davidson Bogel Real Estate announces the successful sale of approximately 7 acres in Haslet, Texas, with buyer Encompass Health collaborating closely with landowner Terra Manna, highlighting the area's investment potential.
- Hospital Construction Plans: Encompass Health plans to develop a state-of-the-art 50-bed inpatient rehabilitation hospital on the site, expected to significantly enhance specialized rehabilitative care access in the rapidly growing Haslet submarket to meet rising medical demands.
- Catalyst for Regional Development: The establishment of the new hospital will not only provide much-needed medical services to the community but also serve as a catalyst for continued development in the surrounding area, further driving economic growth and infrastructure improvements in Haslet.
- Market Leadership Position: Encompass Health is the nation's largest provider of inpatient rehabilitation services, treating approximately one in three patients in the U.S., and its commitment to clinical expertise and personalized care enhances its competitive advantage in the market.
See More
Encompass Health Declares Quarterly Cash Dividend
- Quarterly Cash Dividend: Encompass Health's board has declared a cash dividend of $0.19 per share, payable on July 15, 2026, to shareholders of record on July 1, 2026, reflecting the company's commitment to returning value to its investors.
- Industry Leadership: As the largest operator of inpatient rehabilitation hospitals in the U.S., Encompass Health operates 175 hospitals across 39 states and Puerto Rico, leveraging advanced technology and innovative treatments to provide high-quality rehabilitative care, thereby reinforcing its market leadership.
- Honors and Recognition: The company has been recognized as America's Most Awarded Leader in Inpatient Rehabilitation by Newsweek and Statista, and ranks among Fortune's World's Most Admired Companies™, Forbes' America's Best Companies, and Becker's Healthcare's Top Places to Work, enhancing its brand image and competitive position.
- Forward-Looking Statements: The press release includes forward-looking statements regarding potential changes in dividend amounts and timing, highlighting the legal and regulatory risks faced in the healthcare industry, and reminding investors to consider potential uncertainties.
See More
Encompass Health Opens New Rehabilitation Hospital in Pennsylvania
- New Hospital Opening: Encompass Health has launched a new 50-bed rehabilitation hospital in Concord Township, Delaware County, Pennsylvania, now accepting patients, marking a significant expansion in the region.
- Comprehensive Services: The hospital offers rehabilitation services for conditions such as strokes, brain injuries, and spinal cord injuries, with patients receiving a minimum of 15 hours of intensive therapy weekly, aimed at restoring their functional abilities and quality of life.
- Advanced Facilities: The hospital features private patient rooms, state-of-the-art therapy gyms, and activities of daily living suites designed to provide personalized rehabilitation experiences for patients of all mobility levels, enhancing recovery outcomes.
- Strategic Expansion: This marks Encompass Health's tenth hospital in Pennsylvania, with plans to open another facility in Lower Providence, further solidifying its leadership position in the U.S. rehabilitation healthcare market.
See More
Encompass Health Reports Strong Q1 Earnings with Revenue Growth and Guidance Raise
- Significant Revenue Growth: Encompass Health reported a 9% increase in Q1 revenue to $1.59 billion, with adjusted EBITDA rising 11.2% to $348.8 million, reflecting strong market performance and prompting an upward revision of 2026 guidance.
- Improved Patient Outcomes: The discharge community rate improved by 50 basis points to 84.5%, exceeding industry averages, indicating significant progress in enhancing patient outcomes and strengthening the company's competitive position.
- Optimized Human Resource Management: RN turnover decreased to 17.8%, the lowest since 2012, contributing to a 9.4% decline in premium labor spend, showcasing the company's successful strategies in employee retention and development.
- Expansion Plans Implementation: The company plans to open 7 new hospitals and add 100 to 150 beds to existing facilities to meet strong demand for inpatient rehabilitation services, further solidifying its market position and enhancing service capacity.
See More
Encompass Health Reports Strong Q1 2026 Earnings Growth
- Significant Revenue Growth: Encompass Health reported a 9% revenue increase in Q1 2026, reaching $1.59 billion, with adjusted EBITDA rising 11.2% to $348.8 million, indicating strong financial performance amid robust demand for healthcare services.
- Accelerated Expansion Plans: The company plans to open seven more hospitals in 2026, adding a total of 340 beds and increasing existing hospital capacity by 100 to 150 beds, demonstrating its proactive approach to capacity expansion in response to strong market demand.
- Cash Flow and Buybacks: Q1 adjusted free cash flow was $194 million, and the company repurchased approximately 708,000 shares for a total of $71.6 million, reflecting a balanced approach between expansion and shareholder returns.
- Guidance Upgraded for 2026: Based on strong Q1 results, the company raised its 2026 net operating revenue guidance to $6.375 billion to $6.470 billion and adjusted EBITDA expectations to $1.35 billion to $1.38 billion, showcasing management's confidence in future performance.
See More
Encompass Health Q1 Earnings Announcement Scheduled
- Earnings Release Date: Encompass Health (EHC) is set to announce its Q1 2023 earnings on April 30th after market close, with consensus EPS estimated at $1.49 and revenue at $1.57 billion, reflecting an 8.3% year-over-year growth, which could significantly impact the stock price.
- Historical Performance: Over the past two years, EHC has beaten EPS estimates 100% of the time and revenue estimates 75% of the time, which bolsters investor confidence in the upcoming earnings report and reflects the company's strong operational performance.
- Estimate Revision Dynamics: In the last three months, EPS estimates have seen six upward revisions and three downward revisions, while revenue estimates have faced no upward revisions but nine downward adjustments, indicating a potential weakening in market expectations for future revenue growth.
- Future Outlook: Encompass Health targets up to $6.465 billion in revenue by 2026, driven by capacity expansion and regulatory adaptation, and achieving this goal will further enhance the company's market position in the healthcare sector.
See More
Encompass Health Acquires Land for New Rehabilitation Hospital in Texas
- Successful Land Transaction: Davidson Bogel Real Estate announces the successful sale of approximately 7 acres in Haslet, Texas, with buyer Encompass Health collaborating closely with landowner Terra Manna, highlighting the area's investment potential.
- Hospital Construction Plans: Encompass Health plans to develop a state-of-the-art 50-bed inpatient rehabilitation hospital on the site, expected to significantly enhance specialized rehabilitative care access in the rapidly growing Haslet submarket to meet rising medical demands.
- Catalyst for Regional Development: The establishment of the new hospital will not only provide much-needed medical services to the community but also serve as a catalyst for continued development in the surrounding area, further driving economic growth and infrastructure improvements in Haslet.
- Market Leadership Position: Encompass Health is the nation's largest provider of inpatient rehabilitation services, treating approximately one in three patients in the U.S., and its commitment to clinical expertise and personalized care enhances its competitive advantage in the market.
See More
Encompass Health Declares Quarterly Cash Dividend
- Quarterly Cash Dividend: Encompass Health's board has declared a cash dividend of $0.19 per share, payable on July 15, 2026, to shareholders of record on July 1, 2026, reflecting the company's commitment to returning value to its investors.
- Industry Leadership: As the largest operator of inpatient rehabilitation hospitals in the U.S., Encompass Health operates 175 hospitals across 39 states and Puerto Rico, leveraging advanced technology and innovative treatments to provide high-quality rehabilitative care, thereby reinforcing its market leadership.
- Honors and Recognition: The company has been recognized as America's Most Awarded Leader in Inpatient Rehabilitation by Newsweek and Statista, and ranks among Fortune's World's Most Admired Companies™, Forbes' America's Best Companies, and Becker's Healthcare's Top Places to Work, enhancing its brand image and competitive position.
- Forward-Looking Statements: The press release includes forward-looking statements regarding potential changes in dividend amounts and timing, highlighting the legal and regulatory risks faced in the healthcare industry, and reminding investors to consider potential uncertainties.
See More
Encompass Health Opens New Rehabilitation Hospital in Pennsylvania
- New Hospital Opening: Encompass Health has launched a new 50-bed rehabilitation hospital in Concord Township, Delaware County, Pennsylvania, now accepting patients, marking a significant expansion in the region.
- Comprehensive Services: The hospital offers rehabilitation services for conditions such as strokes, brain injuries, and spinal cord injuries, with patients receiving a minimum of 15 hours of intensive therapy weekly, aimed at restoring their functional abilities and quality of life.
- Advanced Facilities: The hospital features private patient rooms, state-of-the-art therapy gyms, and activities of daily living suites designed to provide personalized rehabilitation experiences for patients of all mobility levels, enhancing recovery outcomes.
- Strategic Expansion: This marks Encompass Health's tenth hospital in Pennsylvania, with plans to open another facility in Lower Providence, further solidifying its leadership position in the U.S. rehabilitation healthcare market.
See More
Encompass Health Reports Strong Q1 Earnings with Revenue Growth and Guidance Raise
- Significant Revenue Growth: Encompass Health reported a 9% increase in Q1 revenue to $1.59 billion, with adjusted EBITDA rising 11.2% to $348.8 million, reflecting strong market performance and prompting an upward revision of 2026 guidance.
- Improved Patient Outcomes: The discharge community rate improved by 50 basis points to 84.5%, exceeding industry averages, indicating significant progress in enhancing patient outcomes and strengthening the company's competitive position.
- Optimized Human Resource Management: RN turnover decreased to 17.8%, the lowest since 2012, contributing to a 9.4% decline in premium labor spend, showcasing the company's successful strategies in employee retention and development.
- Expansion Plans Implementation: The company plans to open 7 new hospitals and add 100 to 150 beds to existing facilities to meet strong demand for inpatient rehabilitation services, further solidifying its market position and enhancing service capacity.
See More
Encompass Health Reports Strong Q1 2026 Earnings Growth
- Significant Revenue Growth: Encompass Health reported a 9% revenue increase in Q1 2026, reaching $1.59 billion, with adjusted EBITDA rising 11.2% to $348.8 million, indicating strong financial performance amid robust demand for healthcare services.
- Accelerated Expansion Plans: The company plans to open seven more hospitals in 2026, adding a total of 340 beds and increasing existing hospital capacity by 100 to 150 beds, demonstrating its proactive approach to capacity expansion in response to strong market demand.
- Cash Flow and Buybacks: Q1 adjusted free cash flow was $194 million, and the company repurchased approximately 708,000 shares for a total of $71.6 million, reflecting a balanced approach between expansion and shareholder returns.
- Guidance Upgraded for 2026: Based on strong Q1 results, the company raised its 2026 net operating revenue guidance to $6.375 billion to $6.470 billion and adjusted EBITDA expectations to $1.35 billion to $1.38 billion, showcasing management's confidence in future performance.
See More
Encompass Health Q1 Earnings Announcement Scheduled
- Earnings Release Date: Encompass Health (EHC) is set to announce its Q1 2023 earnings on April 30th after market close, with consensus EPS estimated at $1.49 and revenue at $1.57 billion, reflecting an 8.3% year-over-year growth, which could significantly impact the stock price.
- Historical Performance: Over the past two years, EHC has beaten EPS estimates 100% of the time and revenue estimates 75% of the time, which bolsters investor confidence in the upcoming earnings report and reflects the company's strong operational performance.
- Estimate Revision Dynamics: In the last three months, EPS estimates have seen six upward revisions and three downward revisions, while revenue estimates have faced no upward revisions but nine downward adjustments, indicating a potential weakening in market expectations for future revenue growth.
- Future Outlook: Encompass Health targets up to $6.465 billion in revenue by 2026, driven by capacity expansion and regulatory adaptation, and achieving this goal will further enhance the company's market position in the healthcare sector.
See More
